Brief: FDA To Review Two Modified Risk Tobacco Product Renewal Applications From 22nd Century Group
12/05/2026 18:25
May 12 (Reuters) - FDA: FDA: FILED TWO MODIFIED RISK TOBACCO PRODUCT RENEWAL APPLICATIONS FOR SCIENTIFIC REVIEW FROM 22ND CENTURY GROUP Further company coverage: XXII.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on 22nd Century
See all newsNASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: FDA To Review Two Modified Risk Tobacco Product Renewal Applications From 22nd Century Group
22nd Century Group Q4 losses narrow on market expansion, improved margins